Adma Biologics reported $-13764000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agile Therapeutics AGRX:US USD -19666000 7.45M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Novavax NVAX:US USD -166141000 342.93M
Omeros OMER:US USD -54792000 13.1M
Takeda 4502:JP JPY 64.55B 90.92B